Improved R2* measurements in myocardial iron overload

被引:134
作者
Ghugre, NR
Enriquez, CM
Coates, TD
Nelson, MD
Wood, JC
机构
[1] Univ So Calif, Div Cardiol, Keck Sch Med, Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
[2] Univ So Calif, Dept Hematol Oncol, Keck Sch Med, Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
[3] Univ So Calif, Dept Radiol, Keck Sch Med, Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
关键词
iron; myocardium; heart; relaxivity (R2*); susceptibility artifact;
D O I
10.1002/jmri.20467
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];
摘要
Purpose: To optimize R2*(1/T2*) measurements for cardiac iron detection in sickle cell and thalassemia patients. Materials and Methods: We studied 31 patients with transfusion-dependent sickle cell disease and 48 patients with thalassemia major; myocardial R2* was assessed in a single midpapillary slice using a gated gradient-echo pulse sequence. Pixel-wise maps were coregistered among the patients to determine systematic spatial fluctuations in R2*. The contributions of minimum TE, echo spacing, signal-decay model, and region-of-interest (ROI) choice were compared in synthetic and acquired images. Results: Cardiac relaxivity demonstrated characteristic circumferential variations regardless of the degree of iron overload. Within the interventricular septum, a gradient in R2* from right to left ventricle was noted at high values. Pixel-wise and ROI techniques yielded nearly identical values. Signal decay was exponential but a constant offset or second exponential term was necessary to avoid underestimation at high iron concentration. Systematic underestimation of R2* was observed for higher minimum TE, limiting the range of iron concentrations that can be profiled. Fat-water oscillations, although detectable, represented only 1% of the total sign. Conclusion: Clinical cardiac R2* measurements should be restricted to the interventricular septum and should have a minimum TE <= 2 msec. ROI analysis techniques are accurate; however, offset-correction is essential.
引用
收藏
页码:9 / 16
页数:8
相关论文
共 31 条
[1]
Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia [J].
Anderson, LJ ;
Wonke, B ;
Prescott, E ;
Holden, S ;
Walker, JM ;
Pennell, DJ .
LANCET, 2002, 360 (9332) :516-520
[2]
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload [J].
Anderson, LJ ;
Holden, S ;
Davis, B ;
Prescott, E ;
Charrier, CC ;
Bunce, NH ;
Firmin, DN ;
Wonke, B ;
Porter, J ;
Walker, JM ;
Pennell, DJ .
EUROPEAN HEART JOURNAL, 2001, 22 (23) :2171-2179
[3]
Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2*cardiovascular magnetic resonance [J].
Anderson, LJ ;
Westwood, MA ;
Holden, S ;
Davis, B ;
Prescott, E ;
Wonke, B ;
Porter, JB ;
Walker, JM ;
Pennell, DJ .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (03) :348-355
[4]
IRON IN HEART - ETIOLOGY AND CLINICAL SIGNIFICANCE [J].
BUJA, LM ;
ROBERTS, WC .
AMERICAN JOURNAL OF MEDICINE, 1971, 51 (02) :209-&
[5]
Hepatic hemosiderosis in non-human primates: Quantification of liver iron using different field strengths [J].
Bulte, JWM ;
Miller, GF ;
Vymazal, J ;
Brooks, RA ;
Frank, JA .
MAGNETIC RESONANCE IN MEDICINE, 1997, 37 (04) :530-536
[6]
CARDIAC ALTERATIONS IN 36 CONSECUTIVE PATIENTS WITH IDIOPATHIC HEMOCHROMATOSIS - POLYGRAPHIC AND ECHOCARDIOGRAPHIC EVALUATION [J].
CECCHETTI, G ;
BINDA, A ;
PIPERNO, A ;
NADOR, F ;
FARGION, S ;
FIORELLI, G .
EUROPEAN HEART JOURNAL, 1991, 12 (02) :224-230
[7]
An interior trust region approach for nonlinear minimization subject to bounds [J].
Coleman, TF ;
Li, YY .
SIAM JOURNAL ON OPTIMIZATION, 1996, 6 (02) :418-445
[8]
Ehlers K H, 1980, Ann N Y Acad Sci, V344, P397
[9]
Haacke EM, 1999, MAGNETIC RESONANCE I
[10]
Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool [J].
Jensen, PD ;
Jensen, FT ;
Christensen, T ;
Eiskjaer, H ;
Baandrup, U ;
Nielsen, JL .
BLOOD, 2003, 101 (11) :4632-4639